Diabetes, Vol 42, Issue 10 1383-1391, Copyright © 1993 by American Diabetes Association

ARTICLES

Repair of pancreatic beta-cells. A relevant phenomenon in early IDDM?

DL Eizirik, S Sandler and JP Palmer
Department of Medical Cell Biology, Uppsala University, Sweden.

Most studies dealing with the pathogenesis of IDDM have emphasized the immune assault against beta-cells. In this perspective, we review the data that suggest that the beta-cell destruction of IDDM depends on a balance between beta-cell damage and repair. The progressive beta-cell damage leading to IDDM seems to follow markedly different temporal courses in individual patients. Some individuals at high risk for developing IDDM, and presenting with impaired beta-cell function, appear to recover beta-cell function when followed prospectively. Moreover, after the clinical onset of IDDM, most patients experience a transitory period of improved insulin secretion. In vitro and in vivo experimental data suggest that beta-cells are indeed able to repair themselves after damage. Dispersed beta-cells or whole islets can survive and regain their function after a toxic assault. Furthermore, the abnormal insulin release and glucose oxidation of islets isolated from NOD mice during the prediabetic period is completely restored after 1 wk in tissue culture. Finally, treatment of NOD mice with monoclonal antibodies directed against infiltrating T-cells reverses the altered glucose metabolism of beta-cells. Note that beta-cell repair after exposure to different toxic agents can be enhanced both in vivo and in vitro. Potential enhancers of beta-cell repair are nicotinamide, glucose, protein-rich diets, and branched chain amino acids. A basic question that remains to be answered is the nature of the repair mechanisms triggered by beta-cells.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Rydgren, D. Bengtsson, and S. Sandler Complete Protection Against Interleukin-1{beta}-Induced Functional Suppression and Cytokine-Mediated Cytotoxicity in Rat Pancreatic Islets In Vitro Using an Interleukin-1 Cytokine Trap. Diabetes, May 1, 2006; 55(5): 1407 - 1412. [Abstract] [Full Text] [PDF]

				E Ludvigsen, M Stridsberg, E T Janson, and S Sandler Expression of somatostatin receptor subtypes 1-5 in pancreatic islets of normoglycaemic and diabetic NOD mice Eur. J. Endocrinol., September 1, 2005; 153(3): 445 - 454. [Abstract] [Full Text] [PDF]

				S. Muntoni, P. Cocco, G. Aru, F. Cucca, and S. Muntoni Nutritional factors and worldwide incidence of childhood type 1 diabetes Am. J. Clinical Nutrition, June 1, 2000; 71(6): 1525 - 1529. [Abstract] [Full Text] [PDF]

				M. I. Darville, Y.-S. Ho, and D. L. Eizirik NF-{kappa}B Is Required for Cytokine-Induced Manganese Superoxide Dismutase Expression in Insulin-Producing Cells Endocrinology, January 1, 2000; 141(1): 153 - 162. [Abstract] [Full Text] [PDF]

				T. Linn, C. Strate, and K. Schneider Diet Promotes {beta}-Cell Loss by Apoptosis in Prediabetic Nonobese Diabetic Mice Endocrinology, August 1, 1999; 140(8): 3767 - 3773. [Abstract] [Full Text]

				Z. Ling, M.-C. Chen, A. Smismans, D. Pavlovic, F. Schuit, D. L. Eizirik, and D. G. Pipeleers Intercellular Differences in Interleukin 1{beta}-Induced Suppression of Insulin Synthesis and Stimulation of Noninsulin Protein Synthesis by Rat Pancreatic {beta}-Cells Endocrinology, April 1, 1998; 139(4): 1540 - 1545. [Abstract] [Full Text] [PDF]